These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7687727)

  • 1. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.
    Mochizuki N; Uchida S; Miyata H
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):983-95. PubMed ID: 7687727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H
    Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular pharmacology of RS-1893, an orally active cardiotonic agent with arterial and venous vasodilator actions.
    Miyake S; Shiga H; Koike H; Mizuno H; Yorikane R; Oda T; Iijima Y; Kumakura S; Morisawa Y
    Jpn J Pharmacol; 1988 Jul; 47(3):273-83. PubMed ID: 2851676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of RG W-2938: a cardiotonic agent with vasodilator activity.
    Barrett JA; Woltmann RF; Swillo RS; Kasiewski C; Faith WC; Campbell HF; Perrone MH
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):537-45. PubMed ID: 1706794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.
    Duncker DJ; Hartog JM; Levinsky L; Verdouw PD
    Br J Pharmacol; 1987 Jul; 91(3):609-15. PubMed ID: 3607369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
    Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium.
    Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
    Brunkhorst D; v der Leyen H; Meyer W; Nigbur R; Schmidt-Schumacher C; Scholz H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):575-83. PubMed ID: 2549430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
    J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
    Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
    J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
    Nagy L; Pollesello P; Haikala H; Végh Á; Sorsa T; Levijoki J; Szilágyi S; Édes I; Tóth A; Papp Z; Papp JG
    Eur J Pharmacol; 2016 Mar; 775():120-9. PubMed ID: 26872993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
    Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005.
    Dundore RL; Pagani ED; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):14-21. PubMed ID: 7723343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular pharmacology of the vasodilator-cardiotonic agent, 349U85.
    Steffen RP; Wastila WB
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):579-89. PubMed ID: 1280714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 3rd communication: stereoselectivity of the enantiomers in cardiovascular effects.
    Sugawara H; Hino M; Yoshimura A; Yoshioka K; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):412-9. PubMed ID: 10367103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.